Tusibí: Neither 2C-B nor “pink cocaine”
DOI:
https://doi.org/10.21134/1093Keywords:
Pink Cocaine, 2C-B, Tusi, Harm Reduction, HealthAbstract
Tusi or tusibí is a psychoactive substance with a highly variable composition, frequently misidentified as 2C-B and referred to as "pink cocaine" in media and law enforcement narratives. Originating in Colombia, its use has spread throughout Latin America and Europe, including Spain, particularly in recreational settings. Although its general prevalence remains low, studies conducted between 2020 and 2024 report annual use rates of 15–20?% among recreational drug users. Analysis of 470 samples reveals that tusi primarily contains ketamine (93.2?%) and MDMA (92.1?%), with minimal presence of 2C-B (3.6?%) and cocaine (0.2?%). It is mostly consumed intranasally, often in combination with alcohol or other substances such as MDMA, increasing associated risks. Major harms are linked to the unpredictability of its composition, the misinformation surrounding its identity, and polydrug use. The findings underscore the need for harm reduction strategies, improved public information, and enhanced drug monitoring systems.
.
Downloads
References
Anderson, D. J., Zhou, J., Cao, D., McDonald, M., Guenther, M., Hasoon, J., Viswanath, O., Kaye, A. D., & Urits, I. (2022). Ketamine-Induced Cystitis: A Comprehensive Review of the Urologic Effects of This Psychoactive Drug. Health Psychology Research, 10(3), 38247. https://doi.org/10.52965/001c.38247
Barrios, K. P., Connolly, D. J., Ferris, J. A., Maier, L. J., Barratt, M. J., Winstock, A. R., Puljevi?, C., & Gilchrist, G. (2025). Ketamine use in a large global sample: Characteristics, patterns of use and emergency medical treatment. Journal of Psychopharmacology (Oxford, England), 39(1), 8-22. https://doi.org/10.1177/02698811241273850
Belal, M., Downey, A., Doherty, R., Ali, A., Hashim, H., Kozan, A., Kujawa, M., Pakzad, M., Rashid, T., Osman, N., Sahai, A., & Biers, S. (2024). British Association of Urological Surgeons Consensus statements on the management of ketamine uropathy. BJU International, 134(2), 148-154. https://doi.org/10.1111/bju.16404
Chan, E. O., Chan, V. W., Tang, T. S., Cheung, V., Wong, M. C., Yee, C., Ng, C., & Teoh, J. Y. (2022). Systematic review and meta-analysis of ketamine-associated uropathy. Hong Kong Medical Journal, 28(6), 466-474. https://doi.org/10.12809/hkmj209194
Corazza, O., Assi, S., & Schifano, F. (2013). From “Special K” to “Special M”: the evolution of the recreational use of ketamine and methoxetamine. CNS neuroscience & therapeutics, 19(6), 454-460. https://doi.org/10.1111/cns.12063
Échele Cabeza. (2018, agosto 17). Si no es 2CB (tuci), ¿entonces qué es? Échele Cabeza. https://www.echelecabeza.com/sino-es-2cb-tuci-entonces-que-es/
El País. (2019, abril 12). La Guardia Civil efectúa su mayor incautación de nexus en España. https://elpais.com/politica/2019/04/12/actualidad/1555063206_913950.html
Energy Control. (s.f.). Tusi. Energy Control. Recuperado de https://energycontrol.org/sustancias/tusi/
Fernández, D., Navarro, J., Vidal, C., & de la Vega, B. (2024). Energy Control: más de 25 años rompiendo con la prohibición del consumo de drogas. Revista Internacional De Educación Y Análisis Social Crítico Mañé, Ferrer & Swartz, 2(1), 204–249. https://doi.org/10.51896/easc.v2i1.542
Ford, A. (2022). Tusi: el sicodélico cóctel rosa que engañó a Latinoamérica. Insight Crime. Recuperado de https://es.insightcrime.org/noticias/tusi-coctel-sicodelico-rosa-engano-latinoamerica/
González, D., Torrens, M., & Farré, M. (2015). Acute effects of the novel psychoactive drug 2C?B on emotions. BioMed Research International, 2015(1), 643878. https://doi.org/10.1155/2015/643878
Hospital Clinic (2025). Informe Actcividad Toxicología 2024. Recuperado de https://www.clinicbarcelona.org/noticias/el-clinic-alerta-sobre-el-aumento-del-uso-de-nuevas-sustancias-psicoactivas-y-nuevos-consumos-de-riesgo
Palamar, J. (2023). Tusi: A new ketamine concoction complicating the drug landscape. American Journal of Drug and Alcohol Abuse, 49(5), 546–550. https://doi.org/10.1080/00952990.2023.2207716
United Nations Office on Drugs and Crime (2022). Tuci, happy water, k-powdered milk – Is the illicit market for ketamine expanding? Global SMART Update, Vol. 27
Policía Nacional. (2016, 25 de junio). La Policía Nacional desmantela dos laboratorios clandestinos donde elaboraban tucibi y adulteraban cocaína. Policía Nacional. https://www.policia.es/_es/comunicacion_prensa_detalle.php?ID=5598#
Redacción Semana. (2012, octubre 27). La droga 2CB, la 'traba' de élite.... Semana. https://www.semana.com/nacion/articulo/la-droga-2cb-la-traba-de-elite/267008/
Sateler, A., et al. (2019). Nombres populares y clasificación de las drogas de abuso ilícitas en Chile. Revista Médica de Chile, 147(12), 1613–1620. https://doi.org/10.4067/S0034-98872019001201613
Van Amsterdam, J., & Van Den Brink, W. (2022). Harm related to recreational ketamine use and its relevance for the clinical use of ketamine. Expert Opinion on Drug Safety, 21(1), 83-94. https://doi.org/10.1080/14740338.2021.1949454
Vidal, C. (2019). Los servicios de análisis de sustancias: un instrumento imprescindible para la reducción de riesgos y daños. Revista Española de Drogodependencias, 44(3), 67-77. https://red.aesed.com/upload/files/articulo5_b_cvidal.pdf
Vidal, C., de la Vega, B., & Navarro, J. (2025b). Los mercados de drogas en España vistos a través de un servicio de análisis de sustancias: MDMA, cocaína y tusi. Barcelona: Fundación Acción, Bienestar y Desarrollo.
Vidal-Giné, C., López, J., & Fernández Piedra, D. (2023). Energy Control: Observatorio de consumos, riesgos y cuidados. Informe Técnico 2022. https://doi.org/10.13140/RG.2.2.33673.93282
Vidal-Giné, C., López, J., & Fernández Piedra, D. (2024). Energy Control: Observatorio de consumos, riesgos y cuidados. Informe Técnico 2023. https://doi.org/10.13140/RG.2.2.26803.64809
Vidal-Giné, C., López, J., & Fernández Piedra, D. (2025a). ENERGY CONTROL: Observatorio de consumos, riesgos y cuidados: Informe técnico 2024. https://doi.org/10.13140/RG.2.2.23089.70241
Downloads
Published
Issue
Section
License
Copyright (c) 2025 Diego Fernández Piedra, Claudio Vidal Giné, Berta de la Vega Moreno
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Authors publishing in this journal agree to the journal's statement of ethical principles and to the following terms:
The rights of the published material shall belong to their respective authors. Articles published in HAAJ may be used under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International license, and may be read, copied, distributed, printed, searched, or linked to in the full text of this journal without prior permission from the publisher or author, provided that HAAJ and the authors are acknowledged and not used for commercial purposes.
Authors may include the work in institutional repositories or other publications as long as this journal is acknowledged and properly cited.
The HAAJ editorial team encourages authors to disseminate their published work through any means (conferences, classes, lectures, talks, etc.) and/or platforms (social networks, repositories, websites, etc.).
HAAJ follows the Core Practices of COPE (Committee on Publication Ethics).
How to Cite
